You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Baxter
Harvard Business School
Merck

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for pancrelipase (amylase;lipase;protease) and what is the scope of patent protection?

Pancrelipase (amylase;lipase;protease) is the generic ingredient in seven branded drugs marketed by Abbvie, Vivus Inc, Digestive Care Inc, Forest Labs Inc, Zenpep, Organon Usa Inc, and Viokace, and is included in seven NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Pancrelipase (amylase;lipase;protease) has ninety-one patent family members in thirty-three countries.

There are six drug master file entries for pancrelipase (amylase;lipase;protease). Five suppliers are listed for this compound.

Summary for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
International Patents:91
US Patents:8
Tradenames:7
Applicants:7
NDAs:7
Drug Master File Entries: 6
Suppliers / Packagers: 5
Clinical Trials: 2
DailyMed Link:PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) at DailyMed
Recent Clinical Trials for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 1
St. Louis UniversityN/A
Digestive Care, Inc.N/A

See all PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) clinical trials

US Patents and Regulatory Information for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zenpep ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-004 Aug 27, 2009 RX Yes No   Start Trial   Start Trial   Start Trial
Zenpep ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-002 Aug 27, 2009 RX Yes No   Start Trial   Start Trial   Start Trial
Zenpep ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-002 Aug 27, 2009 RX Yes No   Start Trial   Start Trial   Start Trial
Zenpep ZENPEP pancrelipase (amylase;lipase;protease) CAPSULE, DELAYED RELEASE;ORAL 022210-006 Jul 13, 2011 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Boehringer Ingelheim
Moodys
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.